BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23036799)

  • 1. Dermatomyositis: a contemporary review for oral health care providers.
    Tanaka TI; Geist SM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):e1-8. PubMed ID: 23036799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous signs of classical dermatomyositis.
    Auriemma M; Capo A; Meogrossi G; Amerio P
    G Ital Dermatol Venereol; 2014 Oct; 149(5):505-17. PubMed ID: 25014587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical features, diagnosis and classification of dermatomyositis.
    Iaccarino L; Ghirardello A; Bettio S; Zen M; Gatto M; Punzi L; Doria A
    J Autoimmun; 2014; 48-49():122-7. PubMed ID: 24467910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis.
    Sontheimer RD
    Curr Opin Rheumatol; 1999 Nov; 11(6):475-82. PubMed ID: 10551671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
    Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
    Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies.
    Dugan EM; Huber AM; Miller FW; Rider LG;
    Dermatol Online J; 2009 Feb; 15(2):1. PubMed ID: 19336018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of oral manifestations and masticatory force in patients with polymyositis and dermatomyositis.
    Márton K; Hermann P; Dankó K; Fejérdy P; Madléna M; Nagy G
    J Oral Pathol Med; 2005 Mar; 34(3):164-9. PubMed ID: 15689230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
    Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
    Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comprehensive understanding and study on idiopathic inflammatory myopathies to improve its diagnosis and treatment].
    Xie QB; Liu G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):792-6. PubMed ID: 24325114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral lichen planus in a dermatomyositis patient that resolved after intravenous immunoglobulin therapy.
    Geist SM; Tanaka TI
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Oct; 118(4):e111-4. PubMed ID: 25241001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical case of the month. 3-year-old boy presenting with a hand rash. Juvenile dermatomyositis.
    Kendrick CG; Poole JC; Nicotri T; Gedalia A; Lopez FA
    J La State Med Soc; 2004; 156(5):235-9; quiz 240. PubMed ID: 15554092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatomyositis and polymyositis: new treatment targets on the horizon.
    Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M
    Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile dermatomyositis in Thai children.
    Singalavanija S; Liamsuwan S; Limpongsanurak W; Raungsuwan S
    J Med Assoc Thai; 2001 Nov; 84(11):1527-33. PubMed ID: 11853294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatomyositis: current controversies 1987.
    Callen JP
    Adv Dermatol; 1988; 3():3-23. PubMed ID: 3152826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amyopathic dermatomyositis].
    Dankó K; Simkovics E; Nagymáté O; Aleksza M; Szegedi A
    Orv Hetil; 2002 Feb; 143(7):341-6. PubMed ID: 11892468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of cutaneous dermatomyositis.
    Lam C; Vleugels RA
    Dermatol Ther; 2012; 25(2):112-34. PubMed ID: 22741932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
    Khan S; Christopher-Stine L
    Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining cancer risk in dermatomyositis. Part I.
    Madan V; Chinoy H; Griffiths CE; Cooper RG
    Clin Exp Dermatol; 2009 Jun; 34(4):451-5. PubMed ID: 19522981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies.
    Dugan EM; Huber AM; Miller FW; Rider LG;
    Dermatol Online J; 2009 Feb; 15(2):2. PubMed ID: 19336019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.